Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
8 | 4 | POLYMER SCIENCE//CHEMISTRY, PHYSICAL//MATERIALS SCIENCE, MULTIDISCIPLINARY | 1554940 |
88 | 3 | INTERNATIONAL JOURNAL OF PHARMACEUTICS//DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY//CHITOSAN | 80849 |
1612 | 2 | ADJUVANT//M CELLS//ISCOM | 7315 |
6629 | 1 | IMMUNOBIOL VACCINE//MUCOSAL ADJUVANT//CHOLERA TOXIN | 1490 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | IMMUNOBIOL VACCINE | address | 474360 | 4% | 42% | 54 |
2 | MUCOSAL ADJUVANT | authKW | 419881 | 3% | 39% | 51 |
3 | CHOLERA TOXIN | authKW | 230428 | 7% | 11% | 103 |
4 | RECOMBINANT CHOLERA TOXIN B SUBUNIT RCTB | authKW | 211505 | 1% | 100% | 10 |
5 | INTRANASAL IMMUNIZATION | authKW | 207607 | 2% | 27% | 36 |
6 | MUCOSAL VACCINE | authKW | 179523 | 3% | 19% | 44 |
7 | MUCOSAL IMMUNITY | authKW | 126219 | 7% | 6% | 98 |
8 | HEAT LABILE ENTEROTOXIN | authKW | 116561 | 1% | 26% | 21 |
9 | NASAL INFLUENZA VACCINE | authKW | 108772 | 0% | 86% | 6 |
10 | MUCOSAL IMMUNIZATION | authKW | 101017 | 2% | 16% | 29 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Immunology | 36399 | 73% | 0% | 1090 |
2 | Medicine, Research & Experimental | 5142 | 23% | 0% | 338 |
3 | Infectious Diseases | 3776 | 16% | 0% | 231 |
4 | Virology | 729 | 6% | 0% | 86 |
5 | Microbiology | 467 | 9% | 0% | 130 |
6 | Biotechnology & Applied Microbiology | 42 | 4% | 0% | 57 |
7 | Veterinary Sciences | 35 | 3% | 0% | 42 |
8 | Pharmacology & Pharmacy | 33 | 6% | 0% | 83 |
9 | Allergy | 30 | 1% | 0% | 13 |
10 | Biochemical Research Methods | 24 | 2% | 0% | 35 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | IMMUNOBIOL VACCINE | 474360 | 4% | 42% | 54 |
2 | WITEBSKY MICROBIAL PATHOGENESIS IMMUNOL | 86298 | 2% | 14% | 29 |
3 | MUCOSAL IMMUNOL | 78569 | 3% | 8% | 47 |
4 | PREVENT VIRAL DIS | 69214 | 0% | 55% | 6 |
5 | PROD 1 | 69214 | 0% | 55% | 6 |
6 | U721 | 52871 | 0% | 50% | 5 |
7 | UMR 721 | 42301 | 0% | 100% | 2 |
8 | HUMAN VACCINE PROD | 40668 | 0% | 38% | 5 |
9 | MICROBIAL DIS MUCOSAL IMMUNOL | 38069 | 0% | 60% | 3 |
10 | 21ST CENTURY COE PROGRAM ZOONOSIS CONTROL | 33041 | 0% | 31% | 5 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | VACCINE | 92392 | 19% | 2% | 284 |
2 | INFECTION AND IMMUNITY | 15214 | 9% | 1% | 139 |
3 | MUCOSAL IMMUNOLOGY | 6706 | 1% | 2% | 17 |
4 | JOURNAL OF IMMUNOLOGY | 5610 | 8% | 0% | 121 |
5 | SCANDINAVIAN JOURNAL OF IMMUNOLOGY | 3536 | 2% | 1% | 31 |
6 | IMMUNOLOGY | 3218 | 2% | 0% | 37 |
7 | EUROPEAN JOURNAL OF IMMUNOLOGY | 2890 | 3% | 0% | 43 |
8 | EXPERT REVIEW OF VACCINES | 2319 | 1% | 1% | 12 |
9 | CLINICAL AND VACCINE IMMUNOLOGY | 1737 | 1% | 1% | 15 |
10 | HUMAN VACCINES & IMMUNOTHERAPEUTICS | 1563 | 1% | 1% | 12 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |